Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older

NCT02677610 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: MSRD-100
DRUG: Vehicle

Sponsor

Merz North America, Inc.